Home64Z • FRA
add
Keymed Biosciences Inc
Previous close
€8.50
Day range
€8.40 - €8.40
Year range
€4.36 - €8.40
Market cap
23.67B HKD
Avg Volume
5.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Revenue
Net income
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 108.78M | -41.74% |
Operating expense | 329.85M | 10.39% |
Net income | -221.90M | -148.63% |
Net profit margin | -203.99 | -326.76% |
Earnings per share | — | — |
EBITDA | -229.61M | -135.16% |
Effective tax rate | 0.28% | — |
Balance Sheet
Total assets
Total liabilities
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 1.92B | -10.76% |
Total assets | 4.22B | 11.97% |
Total liabilities | 1.44B | 11.71% |
Total equity | 2.77B | — |
Shares outstanding | 283.64M | — |
Price to book | 0.87 | — |
Return on assets | -14.72% | — |
Return on capital | -17.42% | — |
Cash Flow
Net change in cash
| (CNY) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -221.90M | -148.63% |
Cash from operations | — | — |
Cash from investing | — | — |
Cash from financing | — | — |
Net change in cash | — | — |
Free cash flow | — | — |
About
CEO
Founded
Sep 2016
Website
Employees
1,625
